During the past decade, Allami Szivkorhaz Balatonfured conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allami Szivkorhaz Balatonfured" are "Acute Myocardial Infarction" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease (CAD)" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Allami Szivkorhaz Balatonfured" in a lesser frequency.

Most popular intervention types in "Allami Szivkorhaz Balatonfured" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evolocumab" (2 trials), "Placebo" (2 trials), "BAY2433334" (1 trials), "BAY2433334 matching placebo" (1 trials) and "Clopidogrel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allami Szivkorhaz Balatonfured" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Allami Szivkorhaz Balatonfured". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Allami Szivkorhaz Balatonfured, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allami Szivkorhaz Balatonfured, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".